Physical Activity Post-Cancer for Adolescents and Young Adults (PAPAYA)

August 9, 2023 updated by: Smita Dandekar, Milton S. Hershey Medical Center

Physical Activity Post-Cancer for Adolescents and Young Adults (PAPAYA)

The Physical Activity Post-Cancer for Adolescents and Young Adults (PAPAYA) trial aims to carry out a pilot randomized controlled trial among 10-17 year-old adolescents and young adults, at least 1 year and up to 5 years post-cancer treatment. The trial will evaluate the effects of a 12 week physical activity intervention to improve patient reported outcomes and physical function, in comparison to a delayed-intervention control group.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The investigators will recruit 40 adolescents and young adults at least 1 year, and up to 5 years post-cancer treatment, and randomize them (20 randomized to each condition) to either a 12-week physical activity intervention to improve patient-reported outcomes and physical function, or delayed-intervention control group.

Participants randomized to the intervention group: The physical activity intervention will be structured to increase moderate-to-vigorous intensity aerobic physical activity, to achieve the 60 minute goal, five days per week. The intervention will also include weekly support calls from research staff. The physical activity intervention will be individualized by research staff according to the adolescents and young adults' health status, results from the physical fitness assessment, and most recent week's achieved minutes. The physical activity intervention will be modified during weekly support calls with a study team member, including frequency, intensity, time, and type, to maximize adherence and compliance

Participants randomized to the delayed-intervention control group: They will not receive the physical activity intervention, and they will not receive weekly support calls. Physical activity advice according to the Children's Oncology Group Guidelines for Diet and Physical Activity recommendations will be offered to participants randomized to the delayed-intervention control group following completion of 12-week follow-up.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Hershey, Pennsylvania, United States, 17033
        • Penn State Health Milton S. Hershey Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 17 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Adolescent and young adult inclusion criteria will be as follows:

  1. males and females diagnosed with cancer;
  2. treated at Penn State Health Children's Hospital or Penn State Cancer Institute, Milton S. Hershey Medical Center;
  3. at least 1 year and up to 5 years post-cancer treatment;
  4. being aged between 10 to 17 years old at enrollment;
  5. being able to speak, read and understand the English language;
  6. adolescents and young adults have to be able to assent, and parents/guardians have to be able to consent to the study in an informed manner;
  7. Parent fluency in written and spoken English;
  8. Adolescents and young adults or their parents must have access to a phone or Zoom

Note: The agreement of the attending oncologist will be required for the participation of adolescents and young adults eligible for this study.

Exclusion Criteria:

Adolescent and young adult exclusion criteria will be as follows:

  1. Received follow-up at a location other than Penn State Health Children's Hospital or Penn State Cancer Institute, Milton S. Hershey Medical Center;
  2. Evidence in the medical record of an absolute contraindication for physical activity;
  3. cardiac exclusion criteria: Class II, III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system, history of acute coronary syndromes, uncertain or uncontrolled arrhythmia, uncontrolled hypertension, syncope, acute myocarditis, pericarditis, or endocarditis, acute pulmonary embolus or pulmonary infarction, thrombosis of lower extremities, suspected dissecting aneurysm, pulmonary edema, respiratory failure, acute non-cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise, mental impairment leading to inability to cooperate;
  4. History of refractory or recurrent diseases
  5. Already meeting physical activity guidelines.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Physical activity intervention group
The physical activity intervention will be structured to increase moderate-to-vigorous intensity aerobic physical activity, to achieve the 60-minute goal, five days per week. The intervention will also include weekly support calls from research staff to improve compliance to physical activity intervention.
The main structure of the physical activity program will focus on increasing physical activity. Physical activity will initially start at a duration of 15-30 minute bouts, and at rate of perceived exertion levels of 5-6 (somewhat hard). Over the course of the intervention, goals will be set to progress to 60 minutes of continuous physical activity, at a rate of perceived exertion level of 5-6 (somewhat hard). Participants will be instructed on the use of the ratings of the perceived exertion scale (Borg's RPE 1-10 scale). Participants will be instructed to walk, or engage in other forms of leisure-time physical activity to achieve these goals (cycling, running, swimming, etc). As the adolescent and young adults' health and fitness status improve, frequency, intensity, and session duration will be modified accordingly during weekly support calls. Moreover, goals will be responsive to the most recent week's achieved minutes and rate of perceived exertion.
Other: Delayed-intervention control group
Participants randomized to the delayed-intervention control group will serve as the control group for 12 weeks, and will not receive physical activity intervention during this time and will not receive weekly support calls. After completion of the control group, participants will be offered physical activity advice according to the Children's Oncology Group Guidelines for Diet and Physical Activity recommendations. This delayed-intervention control group design is used not only to boost recruitment, but to eventually confer the benefits of physical activity to all those who enter the trial.
The main structure of the physical activity program will focus on increasing physical activity. Physical activity will initially start at a duration of 15-30 minute bouts, and at rate of perceived exertion levels of 5-6 (somewhat hard). Over the course of the intervention, goals will be set to progress to 60 minutes of continuous physical activity, at a rate of perceived exertion level of 5-6 (somewhat hard). Participants will be instructed on the use of the ratings of the perceived exertion scale (Borg's RPE 1-10 scale). Participants will be instructed to walk, or engage in other forms of leisure-time physical activity to achieve these goals (cycling, running, swimming, etc). As the adolescent and young adults' health and fitness status improve, frequency, intensity, and session duration will be modified accordingly during weekly support calls. Moreover, goals will be responsive to the most recent week's achieved minutes and rate of perceived exertion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability-the proportion of adolescents and young adults who agree to participate
Time Frame: Baseline

The proportion of adolescents and young adults who agree to participate among those deemed eligible by the attending oncologist

Range 0-100%-Higher scores indicate greater acceptability

Baseline
Feasibility-the proportion of adolescents and young adults who complete at least 50% of the physical activity intervention
Time Frame: Baseline to week 12

The percentage of those randomized to the physical activity intervention that complete at least 50% of the physical activity intervention. Participants will be instructed by a project manager during weekly support calls to accumulate a specific amount of physical activity each week. Participants who self-report completing at least 50% of the physical activity, determined by the Godin-Shephard Leisure-Time Physical Activity Questionnaire, will be deemed compliant.

Range 0-100%-Higher scores indicate greater feasibility

Baseline to week 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient reported outcomes-physical function mobility
Time Frame: Baseline

the physical function mobility assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater physical function mobility

Baseline
Patient reported outcomes-physical function mobility
Time Frame: week 12

the physical function mobility assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater physical function mobility

week 12
Patient reported outcomes-anxiety
Time Frame: Baseline

the anxiety assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater anxiety

Baseline
Patient reported outcomes-anxiety
Time Frame: Week 12

the anxiety assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater anxiety

Week 12
Patient reported outcomes-depressive symptoms
Time Frame: baseline

the depressive symptoms assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater depressive symptoms

baseline
Patient reported outcomes-depressive symptoms
Time Frame: Week 12

the depressive symptoms assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater depressive symptoms

Week 12
Patient reported outcomes-fatigue
Time Frame: baseline

the fatigue assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater fatigue

baseline
Patient reported outcomes-fatigue
Time Frame: week 12

the fatigue assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater fatigue

week 12
Patient reported outcomes-peer relationships
Time Frame: baseline

the peer relationships assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater peer relationships

baseline
Patient reported outcomes-peer relationships
Time Frame: week 12

the peer relationships assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater peer relationships

week 12
Patient reported outcomes-social isolation
Time Frame: baseline

the social isolation assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater social isolation

baseline
Patient reported outcomes-social isolation
Time Frame: week 12

the social isolation assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater social isolation

week 12
Patient reported outcomes-pain interference
Time Frame: baseline

the pain interference assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater pain interference

baseline
Patient reported outcomes-pain interference
Time Frame: week 12

the pain interference assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater pain interference

week 12
Patient reported outcomes-pain intensity
Time Frame: baseline

the pain intensity assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 0-10, higher scores indicate greater pain intensity

baseline
Patient reported outcomes-pain intensity
Time Frame: week 12

the pain intensity assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 0-10, higher scores indicate greater pain intensity

week 12
Patient reported outcomes-sleep disturbance
Time Frame: baseline

the sleep disturbance assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater sleep disturbance

baseline
Patient reported outcomes-sleep disturbance
Time Frame: week 12

the sleep disturbance assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 8-40, higher scores indicate greater sleep disturbance

week 12
Patient reported outcomes-cognitive function
Time Frame: baseline

the cognitive function assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 7-35, higher scores indicate greater cognitive function

baseline
Patient reported outcomes-cognitive function
Time Frame: week 12

the cognitive function assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)

Range 7-35, higher scores indicate greater cognitive function

week 12
physical function-six minute walking test
Time Frame: baseline

The six minute walking test will be administered to assess physical function. Participants will aim to walk as far as possible for 6 minutes.

Further distances indicate greater physical function

baseline
physical function-six minute walking test
Time Frame: week 12

The six minute walking test will be administered to assess physical function. Participants will aim to walk as far as possible for 6 minutes.

Further distances indicate greater physical function

week 12
physical function-30 second chair stand
Time Frame: baseline

The 30 second chair stand test will be administered to assess physical function. Participants will aim to sit and rise out of a chair as many times as possible in 30 seconds.

Greater amounts of sit/stands indicate greater physical function

baseline
physical function-30 second chair stand
Time Frame: week 12

The 30 second chair stand test will be administered to assess physical function. Participants will aim to sit and rise out of a chair as many times as possible in 30 seconds.

Greater amounts of sit/stands indicate greater physical function

week 12
physical function-timed up and go
Time Frame: baseline

The timed up and go test will be administered to assess physical function. Participants will aim to stand up, walk 3 meters, turn around, and walk back to the chair as fast as possible.

Shorter durations indicate greater physical function

baseline
physical function-timed up and go
Time Frame: week 12

The timed up and go test will be administered to assess physical function. Participants will aim to stand up, walk 3 meters, turn around, and walk back to the chair as fast as possible.

Shorter durations indicate greater physical function

week 12

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Costs
Time Frame: Baseline to week 12
Cost of carrying out the intervention will be also a secondary endpoint. We will include staff time, space, and equipment in our estimation of cost per patient to carry out the intervention
Baseline to week 12
Demographics
Time Frame: baseline
At baseline, assented/consented adolescents and young adults will be asked to complete the demographic questionnaires about age (years), sex (male or female), ethnicity (white or black or Asian or Hispanic other/mixed), education level. Adolescents and young adult participants will also be asked age at diagnosis (years), time since diagnosis (months) and diagnosis. Also, treatment interventions including cranial radiation (yes or no) and chemotherapy (yes or no) will be obtained. Adolescents and young adults will be asked if they are currently receiving any mental health-related treatment and/or intervention.
baseline
Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome)
Time Frame: Baseline

Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.

  • Less than 14 units: Insufficiently active
  • 14 to 23 units: Moderately active
  • 24 units or more: Active
Baseline
Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome)
Time Frame: week 1

Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.

  • Less than 14 units: Insufficiently active
  • 14 to 23 units: Moderately active
  • 24 units or more: Active
week 1
Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome)
Time Frame: week 2

Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.

  • Less than 14 units: Insufficiently active
  • 14 to 23 units: Moderately active
  • 24 units or more: Active
week 2
Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome)
Time Frame: week 3

Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.

  • Less than 14 units: Insufficiently active
  • 14 to 23 units: Moderately active
  • 24 units or more: Active
week 3
Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome)
Time Frame: week 4

Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.

  • Less than 14 units: Insufficiently active
  • 14 to 23 units: Moderately active
  • 24 units or more: Active
week 4
Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome)
Time Frame: week 5

Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.

  • Less than 14 units: Insufficiently active
  • 14 to 23 units: Moderately active
  • 24 units or more: Active
week 5
Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome)
Time Frame: week 6

Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.

  • Less than 14 units: Insufficiently active
  • 14 to 23 units: Moderately active
  • 24 units or more: Active
week 6
Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome)
Time Frame: week 7

Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.

  • Less than 14 units: Insufficiently active
  • 14 to 23 units: Moderately active
  • 24 units or more: Active
week 7
Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome)
Time Frame: week 8

Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.

  • Less than 14 units: Insufficiently active
  • 14 to 23 units: Moderately active
  • 24 units or more: Active
week 8
Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome)
Time Frame: week 9

Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.

  • Less than 14 units: Insufficiently active
  • 14 to 23 units: Moderately active
  • 24 units or more: Active
week 9
Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome)
Time Frame: week 10

Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.

  • Less than 14 units: Insufficiently active
  • 14 to 23 units: Moderately active
  • 24 units or more: Active
week 10
Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome)
Time Frame: week 11

Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.

  • Less than 14 units: Insufficiently active
  • 14 to 23 units: Moderately active
  • 24 units or more: Active
week 11
Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome)
Time Frame: week 12

Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.

  • Less than 14 units: Insufficiently active
  • 14 to 23 units: Moderately active
  • 24 units or more: Active
week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Smita Dandekar, MD, Milton S. Hershey Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 21, 2022

Primary Completion (Actual)

February 27, 2023

Study Completion (Actual)

August 1, 2023

Study Registration Dates

First Submitted

June 9, 2021

First Submitted That Met QC Criteria

June 23, 2021

First Posted (Actual)

July 1, 2021

Study Record Updates

Last Update Posted (Actual)

August 14, 2023

Last Update Submitted That Met QC Criteria

August 9, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00018148

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Childhood Cancer Survivors

Clinical Trials on Physical Activity

Subscribe